Circulating Ang-2 was measured in 162 patients with severe AAV (BVAS/WG≥3, with or without glomerulonephritis) in a clinical trial. The gene discussed is ANGPT2; the disease is anti-neutrophil cytoplasmic antibody-associated vasculitis.